-
RNA-based therapy cures lung cancer
europeanpharmaceuticalreview
April 25, 2019
By turning down the activity of a specific RNA molecule, researchers have cured lung tumours in mice…
-
CDC Provides Clarification of Opioid Prescribing Guideline
drugs
April 25, 2019
CDC Provides Clarification of Opioid Prescribing Guideline
-
Cancer Research UK, Ono and LifeArc to identify new cancer drugs
pharmaceutical-technology
April 24, 2019
Cancer Research UK (CRUK) has partnered with Japanese drugmaker Ono Pharmaceutical and not-for-profit LifeArc to identify new immunotherapy drug targets for cancer.
-
Personalizing precision medicine with combination therapies improves outcomes in cancer
worldpharmanews
April 24, 2019
Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets one mutation in their tumor.
-
Merck’s Keytruda gets FDA approval to treat kidney cancer
pharmaceutical-technology
April 24, 2019
Merck has received US Food and Drug Administration (FDA) approval for its anti-PD-1 therapy Keytruda to treat advanced renal cell carcinoma (RCC) patients.
-
MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI for Prostate Cancer Diagnosis
b3cnewswire
April 23, 2019
MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI for Prostate Cancer Diagnosis.
-
Puma licences breast cancer therapy to Pierre Fabre in Europe
pharmaceutical-technology
April 23, 2019
Puma licences breast cancer therapy to Pierre Fabre in Europe.
-
AstraZeneca’s Lynparza gets EC approval for breast cancer
pharmaceutical-technology
April 23, 2019
The European Commission (EC) has approved AstraZeneca drug Lynparza (olaparib) as a monotherapy to treat locally-advanced or metastatic breast cancer in adults.
-
Repurposing cancer drugs may lead to a new approach to treating TB
europeanpharmaceuticalreview
April 22, 2019
Promising experimental cancer chemotherapy drugs may help knock out another life-threatening disease: tuberculosis (TB)…
-
Moleculin Announces Significant Discovery in Lung Cancer Models
americanpharmaceuticalreview
April 22, 2019
Moleculin Announces Significant Discovery in Lung Cancer Models...